Suppr超能文献

甲氨蝶呤治疗胎盘植入

Medical treatment of placenta accreta with methotrexate.

作者信息

Arulkumaran S, Ng C S, Ingemarsson I, Ratnam S S

出版信息

Acta Obstet Gynecol Scand. 1986;65(3):285-6. doi: 10.3109/00016348609155187.

Abstract

Placenta accreta is a rare condition and is associated with considerable maternal morbidity and mortality. Though the surgical approach of hysterectomy is a definitive therapy, there are occasions when conservation of the uterus is desired by the patient. We report a case of placenta accreta successfully treated with intravenous methotrexate. After 2 weeks of treatment no signs of placenta could be visualized on ultrasound examination of the uterus. The patient was discharged after 15 days and has since been well. Such therapy may be useful in exceptional cases in institutions with adequate facilities for careful monitoring and management of the patient.

摘要

胎盘植入是一种罕见的病症,与产妇的高发病率和死亡率相关。尽管子宫切除术的手术方法是一种确定性治疗,但在某些情况下患者希望保留子宫。我们报告一例经静脉注射甲氨蝶呤成功治疗的胎盘植入病例。治疗2周后,子宫超声检查未发现胎盘迹象。患者15天后出院,此后情况良好。在具备对患者进行仔细监测和管理的适当设施的机构中,这种治疗方法在特殊情况下可能会有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验